Internal Medicine, Cardiovascular Disease · Wichita, KS
NPI
1689637647
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
9350 E 35th St N, Ste 101
Wichita, KS, 67226
Phone (316) 265-1308
Groups this clinician bills Medicare through
Medicare paid, 2024
$612K
7,678 services
Medicare patients, 2024
1,616
Average age 76
Drug cost, 2024
$2.3M
17,369 prescriptions
Company payments, 2025
$209
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason T Tauke was code 99214 (office e&m - established), 1,123 times for 751 patients. In total Jason T Tauke billed 7,678 services in 110 codes, and Medicare paid $612K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,123 | 751 | $87.25 | $98K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 964 | 238 | $5.56 | $5,356 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 696 | 341 | $86.06 | $60K |
| 93306 Echocardiography (TTE/TEE) | Office | 627 | 584 | $108.42 | $68K |
| 99213 Office E&M - Established | Office | 588 | 508 | $59.74 | $35K |
| 78452 Myocardial Perfusion Scan | Office | 480 | 472 | $228.15 | $110K |
| 93015 Electrocardiogram | Office | 374 | 365 | $45.09 | $17K |
| 93298 External Electrocardiographic Monitoring | Office | 285 | 44 | $51.43 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 268 | 163 | $57.88 | $16K |
| 99231 Hospital E&M - Subsequent | Facility | 177 | 121 | $36.28 | $6,422 |
| 93000 Electrocardiogram | Office | 167 | 157 | $9.89 | $1,652 |
| 99204 Office E&M - New | Office | 157 | 157 | $117.78 | $18K |
| 36415 Venipuncture Blood Collection | Office | 153 | 78 | $8.65 | $1,323 |
| 93306 Echocardiography (TTE/TEE) | Facility | 143 | 136 | $47.56 | $6,801 |
| 93458 Percutaneous Transcatheterization | Facility | 126 | 125 | $176.63 | $22K |
By year: 2022 $655K for 8,125 services; 2023 $643K for 7,878 services; 2024 $612K for 7,678 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 153 | 78 | $8.65 | $1,323 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason T Tauke prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,049 prescriptions and refills. In total Jason T Tauke wrote 17,369 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,049 | 4,848 | 497 | $11K |
| Metoprolol Succinate Generic | 1,775 | 3,598 | 402 | $12K |
| Clopidogrel Clopidogrel Bisulfate | 1,104 | 2,536 | 264 | $7,124 |
| Eliquis Apixaban | 1,055 | 1,434 | 165 | $832K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 930 | 1,934 | 233 | $16K |
| Furosemide Generic | 633 | 1,181 | 158 | $1,995 |
| Xarelto Rivaroxaban | 594 | 928 | 100 | $517K |
| Spironolactone Generic | 570 | 1,060 | 118 | $3,382 |
| Losartan Potassium Generic | 560 | 1,295 | 145 | $2,918 |
| Rosuvastatin Calcium Generic | 527 | 1,245 | 135 | $3,983 |
| Lisinopril Generic | 508 | 1,158 | 122 | $1,866 |
| Prasugrel Hcl Generic | 440 | 839 | 99 | $24K |
| Flecainide Acetate Generic | 433 | 721 | 90 | $13K |
| Pantoprazole Sodium Generic | 389 | 843 | 85 | $2,301 |
| Jardiance Empagliflozin | 342 | 538 | 56 | $307K |
Brand drugs: 2,945 claims; generic drugs: 14,424 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason T Tauke $209 ($209 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medtronic, Inc. with $139.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.